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Methodological Challenges in Describing 
Medication Dosing Errors in Children  
Heather McPhillips, Christopher Stille, David Smith, John Pearson,  
John Stull, Julia Hecht, Susan Andrade, Marlene Miller, Robert Davis 
Abstract 
Although children are prescribed medications in 30 percent to 50 percent of clinic 
visits, little is known about medication errors in ambulatory pediatrics. In the 
process of completing a study to determine the prevalence of outpatient dosing 
errors, we identified a number of barriers to understanding the epidemiology of 
medication errors in children. These barriers include prescribing medication that 
is not labeled for use in children, discrepancies in published dosing 
recommendations for many medications, unclear guidelines on use of adult dosing 
recommendations for children of different ages and weights, and the lack of 
readily available documented weights to determine appropriate weight-based 
doses for children. In our study of pediatric medication errors, we found a wide 
range of doses prescribed to children for every medication we studied. Before we 
can truly understand medication errors in children and begin developing systems-
based approaches to eliminating these errors, we need better national standards of 
medication doses that are appropriate for children and an improved ability to 
determine errors through databases that include children’s weights as well as 
prescription information. 
Background 
Errors of medication use are among the most common types of medical errors 
and include mistakes of prescribing, dispensing, administering, or monitoring 
medications.1, 2 Children visit the doctor an average of 1.8 times per year, and 
physicians prescribe medication during 30 percent to 50 percent of these 
encounters. In a recent survey of 1,600 American Academy of Pediatrics 
members, pediatricians reported writing prescriptions for 53 percent of patients 
seen during an average workweek. Among those prescriptions, 73 percent were 
for short-term acute illnesses, and 29 percent were for chronic long-term 
illnesses.3 Despite how frequently medications are prescribed in ambulatory 
settings, little is known about the frequency and types of medication errors that 
occur, the clinical importance of these errors, or effective strategies for error 
reduction.  
Children are particularly vulnerable to medication dosing errors because of the 
unique circumstances involved in prescribing medication to children. In the 
ambulatory setting, several factors likely contribute to medication errors include 
the following: (1) an accurate weight must be obtained and correctly transcribed; 
(2) the health care provider may need to convert pounds to kilograms; (3) the 
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health care provider must make rapid weight-based calculations for nearly every 
pediatric prescription he or she writes; (4) the correct preparation and 
concentration (liquid, chewables, tablets) of the medicine must be included in the 
dosage calculation; (5) the total daily dose may need to be divided into multiple 
doses to obtain the appropriate frequency for the medication; (6) communication 
with the parent or caregiver often will occur without the medication present; (7) 
the prescription must be legible and correctly interpreted by the pharmacist; and 
(8) the pharmacist must dispense the appropriate medication in its appropriate 
formulation labeled with the appropriate dose and frequency.  
Tenfold dosing errors in children can easily occur due to a misplaced decimal 
point or a trailing zero.4–6 For example, a 1.0 mg dose may be misread as a 10 mg 
dose and not recognized as an error by a pharmacist because the 10 mg dose is 
still within the range of adult doses for the medication. In addition, health care 
providers must be aware of both the pediatric dosing recommendations (to 
calculate a weight-based dose in mg/kg/day) and adult dosing recommendations 
(to ensure they do not exceed the maximum recommended adult dose in mg/day). 
Furthermore, children cannot always communicate symptoms that may alert 
parents and providers to an adverse drug reaction if a medication overdose or 
underdose is taken by the patient.  
More is known about medication errors in hospitalized patients than in the 
outpatient setting. Errors in medication ordering are the most common cause of 
preventable adverse drug events in hospitalized patients.1, 7 In one adult study, 
half of all preventable adverse drug events occurred at the physician ordering 
stage, and the most common type of error was in medication dosing.1 A study in a 
tertiary care hospital in New York demonstrated that medication dosing errors 
were the most common type of medication prescribing error, and these errors 
occurred at a higher rate in children than adults: 5.89 per 1,000 orders on the 
pediatric service, compared with 4.12 per 1,000 orders on the adult medical 
service.8 In a pharmacy-based review of medication orders in two pediatric 
hospitals, Folli et al.9 found that errors occurred in approximately 0.5 percent of 
medication orders, and the majority of errors were dosing errors. Children under 
the age of 2 years and pediatric intensive care unit patients were at highest risk. In 
the most comprehensive study involving pediatric patients, medication errors 
occurred in nearly 6 percent of all medication orders.7 Serious medication errors, 
those in which harm to the patient was possible, occurred at an alarming rate of 10 
per 100 hospital admissions or 1 percent of all medication orders. Over half of 
these errors were dosing or frequency errors, and the physician ordering the 
medication committed the majority of these errors. Finally, in a retrospective 
study of medication errors reported to the U.S. Food and Drug Administration’s 
Adverse Event Reporting System, administration of the wrong dose of medication 
was the most common type of error resulting in death.10 
The Institute of Medicine (IOM) report on error in medicine identified 
computerization of medication prescribing as an important patient safety 
strategy.2 Computerized order entry, combined with advanced decision support 
systems, has been shown to reduce prescribing errors in hospital settings across 
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many different drug classes.11–15 Computerized order entry reduces medication 
errors by standardizing medication orders. Omissions of dose, route, and 
frequency are eliminated, as are errors from misinterpretation of illegible 
handwriting or use of nonstandard abbreviations. When coupled with 
computerized clinical decision support systems that provide feedback to the 
prescriber at the point of care, computerized prescription ordering has the 
potential to substantially reduce adverse drug events and improve patient safety.  
The majority of outpatient settings do not currently use electronic prescription 
ordering or clinical decision support tools, and few studies have attempted to 
demonstrate the effectiveness of computerized prescription ordering on reducing 
medication errors and/or adverse drug events in ambulatory settings. Furthermore, 
there are many feasibility barriers that impede implementing these tools in 
outpatient practices outside of large hospital settings. These include the large 
financial resources necessary to implement computerized prescription ordering 
with decision support tools and the lack of support staff to train and maintain a 
system, if implemented. 
Before the prevalence of dosing errors in ambulatory pediatrics can be 
studied, it is first necessary to clearly define exactly what a dosing error is. 
Although this task seems straightforward at first glance, many subtleties and 
challenges arose during the course of our studies. Specifically, we grappled with 
these following issues: 
1. Off-label use of medication in children is common, particularly for 
psychotropic medications and other newer classes of medications. 
Many times, pediatric doses for these medications are difficult to find 
and may be extrapolated from adult doses with little scientific 
evidence to support safety and efficacy.  
2. Published sources of pediatric dosing information differ in their 
recommendations for dosing ranges for children, sometimes by as 
much as a two-fold difference in the maximum recommended dose. 
Furthermore, ranges provided for weight-based dosing often 
encompass large ranges, sometimes as much as four-fold differences 
between the minimum recommended dose and the maximum 
recommended dose.  
3. Indications for appropriate adult dosing is in total milligrams per day 
(mg/day) rather than in weight-based milligrams per kilogram per day 
(mg/kg/day), the system for indicating dosing for children.  
4. Determining medication errors in children is only possible with 
accurately documented weight in kilograms.  
This manuscript addresses in further detail the issues and challenges we faced 
in clearly understanding and defining dosing errors in the pediatric ambulatory 
setting. 
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Barriers to safe pediatric prescribing 
Off-label use of medication in children  
As many as 50–75 percent of prescription medications are labeled by the 
manufacturer as having insufficient information on pediatric use, particularly for 
young children and infants.16 In some newer drug classes, there are no 
medications licensed for use in children, leaving providers only the choice of 
prescribing a medication off-label or not prescribing. Safety concerns have been 
raised about medications used in children without adequate testing.17 For 
example, the selective serotonin reuptake inhibitors (SSRIs) have been associated 
with growth attenuation, an adverse effect not found in prelicensure studies in 
adults.18 Some SSRIs have also been associated with increased rates of suicidality 
for adolescents.19 Nonetheless, many medications are appropriately and frequently 
used in children, despite the lack of pediatric labeling. 
When medications are prescribed to children off-label, providers often 
extrapolate pediatric doses from adult doses provided in published sources such as 
health plan formularies or MICROMEDEX©.20 Alternatively, they may rely on 
local expert opinion for pediatric dosing recommendations or obtain pediatric 
doses from published studies in the medical literature. 
In our attempt to define overdoses and underdoses of medications to 
determine potential dosing errors, medications that were not approved for 
children, but were commonly used in children, were particularly problematic. For 
example, oxycodone is an analgesic that is not FDA-approved for use in children. 
However, because of this drug’s ability to relieve pain, it is often used in children 
who do not respond to less potent pain medications. Oxycodone is a narcotic 
analgesic that, if inappropriately overdosed, could cause serious adverse effects, 
including depressed mental status, depressed respiratory drive, and potentially 
even death. We found the recommendations listed in Table 1 when attempting to 
determine appropriate dosing ranges for medication for use in children.  
All of the sources in Table 1 are reliable, reputable sources for pediatric 
dosing of medications. However, a dose at the upper limit of appropriate for one 
Table 1. Dosing information for oxycodone 
Source Recommended pediatric dose* 




No weight-based dose provided. 
MICROMEDEX20 Safety and effectiveness not established in children. 0.2 
to 0.9 mg/kg/day (0.05 to 0.15 mg/kg/dose q 4-6 hours). 
Large regional children’s 
hospital formulary 
0.2 to 1.6 mg/kg/day (0.05 mg/kg/dose q  
4-6 hours to 0.2 mg/kg/dose q 3-4 hours). 
* More complete dosing information is available from each source. 
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source (a children’s hospital formulary) would be considered nearly a twofold 
overdose by another source’s dosing standards (Harriet Lane Handbook21). 
Appropriate dosing of off-label medications can be further complicated by 
some sources recommending doses for children at the lower end of an acceptable 
adult dose. This is often a practical recommendation, as many medications 
licensed only for adult use do not come in liquid formulations, making accurate 
dosing of children more difficult. If liquid preparations are not commercially 
available, providers must dose in fractions of tablets (½ tablet, ¼ tablet). 
However, other sources may recommend weight-based dosing for these same 
medications. Before large scale systematic trials are completed and FDA labeling 
is provided for a medication, it is unclear which dose is most appropriate for 
children. For example, olanzapine is an antipsychotic medication that is not 
currently licensed for use in children under age 18 years. Table 2 represents 
different pediatric doses for olanzapine recommended in several selected sources. 
Table 2. Dosing information for olanzapine 
Source Recommended pediatric dose* 
Harriet Lane Handbook19 Prepubescent: 2.5 mg/day. 
Adolescent: 5 mg/day. 
Health Maintenance Organization’s formulary Adults > 18 years: 5–10 mg/day. No pediatric 
dosing recommendations provided. 
MICROMEDEX20 Safety and effectiveness in children not 
established.  
Expert opinion (pharmacist from University of 
Massachusetts with expertise in 
psychopharmacology) 
0.1 to 0.7 mg/kg/day. 
* More complete dosing information is available from each source. 
Again, an appropriate dose using one recommendation may result in an 
overdose or underdose using the other recommendation. In our study on pediatric 
dosing errors, for example, a 13 year-old child who weighed 80 kg was dispensed 
a prescription for olanzapine of 2.5 mg every day. If the child is considered 
prepubescent, then this dose is appropriate according to the Harriet Lane 
Handbook. However, the dose is 0.03 mg/kg/day, only 30 percent of the minimum 
weight-based dose recommended by an expert in pediatric psychopharmacology. 
Researchers who are attempting to evaluate medication dosing errors often 
will not know which source the provider was using to determine an appropriate 
dose to prescribe to an individual child. This makes categorizing errors difficult. 
One solution is to allow the most liberal definition available (the widest range in 
dosing compiled from various sources). This would provide a conservative 
estimate of medication dosing error rates.  
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Discrepancies in dosing recommendations  
The problem of conflicting dosing recommendations is not limited to off-label 
use in children. Commonly used medications also have different dosing 
recommendations. As an example, amoxicillin is the most commonly used 
medication in children. This one drug accounts for approximately 10 percent of 
all dispensings for children at one large health maintenance organization (HMO). 
Yet recommendations for appropriate dosing vary, depending on the source of 
information. Table 3 illustrates the wide variety of recommendations for 
amoxicillin. 
Table 3. Dosing information for amoxicillin 
Source Recommended pediatric dose* 
Harriet Lane Handbook19 Standard dose: 25–50 mg/kg/day  
High dose: 80–90 mg/kg/day 
Health Maintenance Organization’s 
formulary 
Standard dose: 30–50 mg/kg/day 
High dose: 80–100 mg/kg/day 
MICROMEDEX20 Standard dose: 25–50 mg/kg/day  
High dose: 80–90 mg/kg/day 
Large regional children’s hospital formulary 25–50 mg/kg/day 
* More complete dosing information is available from each source. 
Although there is less variation in the recommended doses for amoxicillin, 
there is still a 10 percent difference in the upper range of recommended 
appropriate doses when Group Health Cooperative’s formulary and the Harriet 
Lane Handbook are compared (Table 3). 
Furthermore, there is a wide range of acceptable doses. If a provider had 
meant to prescribe 25 mg/kg/day, but inadvertently calculated the dose based on 
pounds instead of kilograms (thereby prescribing 2.2 times more medication than 
he or she meant to prescribe), potentially no error would be detected because this 
dose would still fall well within the recommended range. While it may be 
unimportant from a clinical perspective to detect or prevent a child from receiving 
55 mg/kg/day of amoxicillin instead of the intended 25 mg/kg/day, from a 
systems perspective this is a lost opportunity to identify a medication error. Such 
lost opportunities hamper steps to identify systemwide problems and may prevent 
detection of other, potentially more serious errors. If the same child returned with 
a broken arm and was prescribed codeine at the upper limit of an acceptable dose, 
but the provider again used pounds instead of kilograms to calculate the dose, this 
child may come to harm from a 2.2-fold overdose of a narcotic analgesic. Lack of 
standardization of weight-based dosing makes detection of many potential errors 
difficult if not impossible, allowing for missed opportunities for future error 
prevention strategies.  
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Adult dosing guidelines applied to children 
It is often unclear when adult dosing guidelines should be followed. For 
example, the recommended dose of amoxicillin for children is between 25 and 90 
mg/kg/day, with many guidelines recommending higher doses, given the 
increasing level of microbial resistance to the penicillins. However, many 
practitioners in our study of potential medication dosing errors began using the 
minimum adult dose of 750 mg/day for amoxicillin for children as young as age 5 
years diagnosed with otitis media. In this instance, when a child weighs more than 
31 kg, the 750 mg/day adult dose is less than the minimum weight-based dose for 
children (e.g., 25 mg/kg/day x 31 kg = 775 mg/day). This practice contributed to 
nearly 20 percent of amoxicillin doses in our study dispensed to children below the 
age of age 12 years being lower than the recommended weight-based dosing 
minimum.  
Most medications have different recommended doses for children, often based 
on mg/kg/day, but very few medications have clear guidelines on which dose 
might be most appropriate for a given age. Children metabolize many drugs 
differently than adults and have different volumes of distribution for other 
medications. From a research perspective, defining an underdose of a medication 
is difficult if the dose is at least the minimum adult dose, as it is not clear which 
guideline a prescriber might have been using to determine the daily dose for a 
medication. 
Deficient data on weights 
Many medications that are used in children are most appropriately prescribed 
by calculating a weight-based dose in total milligrams per kilogram per day. In 
order to appropriately prescribe these medications, practitioners need an accurate 
weight, recorded either in kilograms (ideal) or in pounds, which can than be 
converted into kilograms. Ideally, weights would always be recorded in kilograms 
to avoid errors in converting pounds into kilograms when calculating medication 
doses; however, parents are often interested in their child’s weight in pounds. In 
clinic visits, weights are therefore often measured and recorded in pounds in the 
medical record. Most retail pharmacies do not mandate inclusion of the child’s 
weight on written prescriptions. Therefore, it is difficult for pharmacies to 
correctly determine if a weight-based dosing error has occurred. 
Researchers or quality assurance members of a health plan attempting to 
retrospectively evaluate appropriateness of doses of medications likewise must 
rely on accurate weights. Their task may be even more difficult, because they 
must rely on documented weights and have no real way of knowing whether a 
documented weight reflects the weight of the patient at the date of the 
prescription. A provider could potentially recognize a pound-to-kilogram 
conversion error or inaccurate weight by noting that a child visually appeared 
more than or less than the recorded weight. 
Although many health care systems are moving toward electronic medical 
records (EMRs), most do not currently have readily available weights in their 
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administrative data sources. In our efforts to study medication dosing errors in 
children in 10 HMOs nationally, only 2 had available weights for children along 
with their pharmacy claims data for the years 1999–2001. Most organizations had 
only the amount of medication dispensed and the days supply. This is insufficient 
information to evaluate potential medication dosing errors in children for two 
primary reasons. First, there is tremendous variation in normal weights for young 
children; therefore, extrapolation of a weight is likely to be inaccurate. Second, 
many children are dispensed medication in liquid formulations, which makes 
determining the amount dispensed to be taken daily potentially inaccurate. A child 
may be prescribed an antibiotic to be taken 5 ml 3 times per day for 10 days (150 
ml total), but be dispensed a 200 ml bottle of medicine with instructions to discard 
the remainder. The automated data will reflect that a 200 ml bottle was dispensed, 
but not the amount prescribed. If the investigator was to attempt to determine the 
daily dose from a 10-day supply, he or she would mistakenly conclude the child 
was prescribed 20 ml per day (200 ml/10-day supply). An alternative source of 
data would be to use the “sig” or directions for use. However, these data are often 
difficult to retrieve electronically, and even when available require manual 
interpretation. 
Health care systems that are interested in monitoring appropriateness of 
pediatric medication doses need electronic accurate weights for rapid assessment 
of appropriateness of medication doses dispensed to young children. Similarly, 
researchers with access to large health organizations’ pharmacy data can only 
readily evaluate medication dosing errors in children if either the database 
contains access to an EMR with weights available, or weights are routinely 
documented in the medical chart and there are sufficient funds and staff available 
to conduct medical record reviews. In our study of dosing errors, the site with an 
EMR had documented weights available for greater than 94 percent of the patients 
selected for the study. In comparison, a documented weight was available only 80 
percent of the time in medical records for the sites using paper charts. Although 
large pharmacy chains often contain complete records of medications dispensed to 
children, they do not routinely require weights or record weights if provided. 
Therefore, opportunities to study medication dosing errors in large pharmacy 
databases from these sources are limited. 
Conclusions 
Although medications are prescribed to millions of children each year in the 
United States, very little information is available on the epidemiology of 
medication errors that occur in the ambulatory setting. Children are particularly 
vulnerable to medication dosing errors because of the relatively complicated 
process of calculating and then prescribing appropriate medication doses for 
them. Researchers and policymakers interested in studying medication dosing 
errors in children should be aware of the many barriers to defining errors in the 
pediatric population.  
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First, lack of evidence to support age-appropriate dosing parameters in many 
medications, particularly medications not licensed for use in children, results in a 
wide range of published recommendations. Discrepancies exist in published 
recommendations for many medications, both labeled and off-label for children. 
This makes defining an appropriate dosing range, and thereby defining 
underdoses and overdoses, problematic. This is a critical limitation to accurately 
ascertaining and describing medication dosing errors. 
Second, the wide range of acceptable weight-based doses makes 
standardization difficult. This is also a barrier to identifying potential errors that 
may be “hidden” within a large acceptable dosing range. In retrospective studies, 
it is difficult to know the dose a health care provider intended to prescribe to a 
child. It is far easier to quantify the appropriateness of the dose a child is 
dispensed. With wide dosing ranges allowable for each weight, prescriber 
calculation errors and other arithmetic errors may be undercounted. 
Third, for many medications that are commonly used in both children and 
adults, it is unclear when it is appropriate to switch from a weight-based pediatric 
dose to an adult based mg/day dosing regimen. Many minimum recommended 
adult doses fall well below the minimum recommended weight-based dose for 
school-aged children. Although we know that children metabolize many 
medications differently than adults, we do not currently have published 
information on when a provider should use adult doses over pediatric doses of 
medications (or vice versa). In our study, we defined an underdose of a 
medication as a medication dispensed below both the adult minimum 
recommended mg/day and the pediatric minimum mg/kg/day. If we had only 
looked for errors in weight-based dosing regimens for children as young as age 4 
or 5, we would have overcounted underdoses for many medications, especially 
psychotropic medications and antibiotics. 
Finally, existing data sources from which medication error detection is 
possible often lack the necessary elements, including weights and complete 
prescription information, to accurately describe errors without a formal, costly 
chart review. More detailed data sources are needed to appropriately target 
interventions to reduce outpatient medication errors in children. 
Children are frequently exposed to prescription drugs. It is imperative that we 
gain a better understanding of the risk factors for medication errors and how to 
effectively prevent medication errors from occurring. Many of the barriers to 
accurately describing the magnitude of the problem exist because of lack of 
standardized evidence-based information about appropriate use of therapeutics in 
children. Our work highlights the need to fund and undertake research that can 
illuminate the critical area of dosing in pediatric medicine to ensure safe use of 
medication in this vulnerable population. 
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